Molecular cloning of a novel variant of the rat soluble guanylate cyclase β2 subunit

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 3, 2004, Pages 472-480

  Okamoto, Hideaki ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

3 RACE; Guanylate cyclase; RT PCR; Tissue distribution; 2 subunit

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; GUANYLATE CYCLASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; ENZYME SUBUNIT; GENE AMPLIFICATION; ISOPRENYLATION; MALE; METHYLATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0348110319     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.08.003     Document Type: Article

References (34)

1. Azam M., Gupta G., Chen W., Wellington S., Warburton D., Danziger R.S. Genetic mapping of soluble guanylyl cyclase genes: implications for linkage to blood pressure in the Dahl rat. Hypertension. 32:1998;149-154.
2. 2 subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma. Biochemical and Biophysical Research Communications. 271:2000;64-69.
3. 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein. The Journal of Biological Chemistry. 270:1995;21109-21113.
4. Carvajal J.A., Germain A.M., Huidobro-Toro J.P., Weiner C.P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. Journal of Cellular Physiology. 184:2000;409-420.
5. Clarke S., Vogel J.P., Deschenes R.J., Stock J. Post-translational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;4643-4647.
6. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochemica et Biophysica Acta. 1411:1999;334-350.
7. Ferrero R., Rodríguez-Pascual F., Miras-Portugal M.T., Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. Journal of Neurochemistry. 75:2000;2029-2039.
8. Garbers D.L. Purification of soluble guanylate cyclase from rat lung. The Journal of Biological Chemistry. 254:1979;240-243.
9. Garbers D.L. The guanylyl cyclase receptors. Methods. 19:1999;477-484.
10. Gibb B.J., Garthwaite J. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. European Journal of Neuroscience. 13:2001;539-544.
11. 12]Ras is inhibited by a cytosol-localized Ras mutant. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;6630-6634.
12. Gupta G., Azam M., Yang L., Danziger R.S. The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. The Journal of Clinical Investigation. 100:1997;1488-1492.
13. Hancock J.F., Magee A.I., Childs J.E., Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
14. Kamisaki Y., Saheki S., Nakane M., Palmieri J.A., Kuno T., Chang B.Y., Waldman S.A., Murad F. Soluble guanylate cyclase from rat lung exists as a heterodimer. The Journal of Biological Chemistry. 261:1986;7236-7241.
15. Kharitonov V.G., Sharma V.S., Magde D., Koesling D. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1. Biochemistry. 38:1999;10699-10706.
16. 2 subunit of soluble guanylyl cyclase. Biochemica et Biophysica Acta. 1494:2000;286-289.
17. Koglin M., Behrends S. Biliverdin IX is an endogenous inhibitor of soluble guanylyl cyclase. Biochemical Pharmacology. 64:2002;109-116.
18. 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. The Journal of Biological Chemistry. 276:2001;30737-30743.
19. Kusakabe T., Suzuki N. The guanylyl cyclase family in medaka fish Oryzias latipes. Zoological Science. 17:2000;131-140.
20. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacological Reviews. 52:2000;375-413.
21. Luo S., Takano M., Asakawa T. Regulation of guanylate cyclase by ATP and dithiothreitol in rat lung membrane: involvement of an insensitive and a sensitive state to ATP/dithiothreitol-stimulation. The Japanese Journal of Pharmacology. 89:2002;72-80.
22. Mundel P., Gambaryan S., Bachmann S., Koesling D., Kriz W. Immunolocalization of soluble guanylyl cyclase subunits in rat kidney. Histochemistry. 103:1995;75-79.
23. Nakane M., Arai K., Saheki S., Kuno T., Buechler W., Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. The Journal of Biological Chemistry. 265:1990;16841-16845.
24. Nighorn A., Byrnes K.A., Morton D.B. Identification and characterization of a novel β subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide. The Journal of Biological Chemistry. 274:1999;2525-2531.
25. Russwurm M., Behrends S., Harteneck C., Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochemical Journal. 335:1998;125-130.
26. 1 guanylyl cyclase to synaptic membranes. The Journal of Biological Chemistry. 276:2001;44647-44652.
27. Stone J.R., Marletta M.A. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 33:1994;5636-5640.
28. Tomita T., Ogura T., Tsuyama S., Imai Y., Kitagawa T. Effects of GTP on bound nitric oxide of soluble guanylate cyclase probed by resonance Raman spectroscopy. Biochemistry. 36:1997;10155-10160.
29. Tomita T., Tsuyama S., Imai Y., Kitagawa T. Purification of bovine soluble guanylate cyclase and ADP-ribosylation on its small subunit by bacterial toxins. The Journal of Biochemistry. 122:1997;531-536.
30. Ujiie K., Drewett J.G., Yuen P.S., Star R.A. Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. The Journal of Clinical Investigation. 91:1993;730-734.
31. Vogel K.M., Hu S., Spiro T.G., Dierks E.A., Yu A.E., Burstyn J.N. Variable forms of soluble guanylyl cyclase: protein-ligand interactions and the issue of activation by carbon monoxide. Journal of Biological Inorganic Chemistry. 4:1999;804-813.
32. Willumsen B.M., Christensen A., Hubbert N.L., Papageorge A.G., Lowy D.R. The p21 ras C-terminus is required for transformation and membrane association. Nature. 310:1984;583-586.
33. Yu S., Avery L., Baude E., Garbers D.L. Guanylyl cyclase expression in specific sensory neurons: a new family of chemosensory receptors. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;3384-3387.
34. Yuen P.S., Potter L.R., Garbers D.L. A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry. 29:1990;10872-10878.